Adam K. Stern, Director at Matinas BioPharma Holdings, Inc. (MTNB), bought 100,000 shares at $1.38 ($138K) on 2017-09-08, disclosed to the SEC on 2017-09-11.
Open-market purchase of $138k MTNB by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.38 | 50,000 | $69K | 50.0% |
| 2 | $1.38 | 50,000 | $69K | 50.0% |
| Total | $1.38 avg | 100,000 | $138K | 100% |
| Filing → |
| MTNB | BUY | 2020-08-24 | $17K | — | Filing → |
| DRIO | BUY | 2020-07-06 | $4K | — | Filing → |
| DRIO | BUY | 2020-06-09 | $15K | — | Filing → |